Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients
- 1 February 1995
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 25 (2) , 291-296
- https://doi.org/10.1016/0272-6386(95)90011-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The spectrum of bone disease in end-stage renal failure—An evolving disorderKidney International, 1993
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- Pulse Oral Calcitriol for the Treatment of Hyperparathyroidism in Patients on Continuous Ambulatory Peritoneal Dialysis: Preliminary ObservationsAmerican Journal of Kidney Diseases, 1992
- Comparison of Intact, Midregion, and Carboxy Terminal Assays of Parathyroid Hormone for the Diagnosis of Bone Disease in Hemodialyzed PatientsJournal of Clinical Endocrinology & Metabolism, 1991
- The ‘Oral 1,25-Dihydroxyvitamin D3 Pulse Therapy’ in Hemodialysis Patients with Severe Secondary HyperparathyroidismNephron, 1991
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremiaKidney International, 1989
- Pharmacological Parathyroidectomy by Oral 1,25(OH)2D3 Pulse TherapyNephron, 1989
- Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium.Journal of Clinical Investigation, 1988
- A sensitive and simplified radioimmunoassay for 1,25-dihydroxyvitamin D3Clinica Chimica Acta; International Journal of Clinical Chemistry, 1984